TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
SIGA

SIGA Technologies Inc

Healthcare · Drug Manufacturers - Specialty & Generic

3.20$ -2.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement SIGA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
344.9% 160.6% 131.5% 136.0% 22.7% 56.4% 20.6% 12.4% 9.4% 12.7% 22.6% 31.4%
-244.9% -60.6% -31.5% -36.0% 77.3% 43.6% 79.4% 87.6% 90.6% 87.3% 77.4% 68.6%
344.9% 160.6% 131.5% 136.0% 2.7% 49.7% 8.8% 7.4% 20.3% 11.7% 8.9% 6.9%
6,401.3% 305.6% 91.5% 100.3% 2.7% 49.6% 11.2% 13.0% 31.7% 15.8% 2.8% 3.3%
430.3% 141.8% 97.6% 107.7% 2.9% 52.3% 11.8% 20.9% 52.0% 27.5% 27.0% 43.5%
-6,677.6% -378.6% -206.9% -153.6% 74.4% -8.7% 67.6% 66.7% 38.5% 59.8% 50.4% 25.1%
14.5% 3.3% 93.8% 120.3% 3.2% 59.0% 2.4% 0.1% 0.8% – – –
-6,749.9% -476.9% -264.8% -312.4% 86.3% -38.1% 58.8% 66.8% 39.8% 62.7% 54.8% 32.1%
1,704.8% 5.7% 0.1% -17.1% -2.1% -11.0% 13.7% 14.9% 9.2% 14.1% 12.2% 7.5%
-8,454.7% -482.5% -264.9% -295.3% 88.4% -27.1% 45.1% 52.0% 30.6% 48.6% 42.7% 24.6%
-6,724.2% -470.6% -169.8% -191.0% 74.5% 22.9% 61.7% 67.2% 40.3% 63.1% 55.2% 32.7%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?